October 15, 2021
The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus...
01:13:44
October 15, 2015
Before Stephen Ubl departed for a job as the chief lobbyist for the pharmaceutical industry, medtech's main man in Washington D.C. sat down with...
00:25:55
June 17, 2022
In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he...
01:19:27